In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies

Purpose: To investigate the pattern of neuromelanin signal intensity loss within the substantia nigra pars compacta (SNpc), locus coeruleus, and ventral tegmental area in Parkinson disease (PD); the specific aims were (a) to study regional magnetic resonance (MR) quantifiable depigmentation in asso...

Full description

Bibliographic Details
Main Authors: Schwarz, Stefan Theodor, Xing, Yue, Tomar, Pragya, Bajaj, Nin, Auer, Dorothee P.
Format: Article
Published: Radiological Society of North America 2016
Online Access:https://eprints.nottingham.ac.uk/39965/
_version_ 1848795955915128832
author Schwarz, Stefan Theodor
Xing, Yue
Tomar, Pragya
Bajaj, Nin
Auer, Dorothee P.
author_facet Schwarz, Stefan Theodor
Xing, Yue
Tomar, Pragya
Bajaj, Nin
Auer, Dorothee P.
author_sort Schwarz, Stefan Theodor
building Nottingham Research Data Repository
collection Online Access
description Purpose: To investigate the pattern of neuromelanin signal intensity loss within the substantia nigra pars compacta (SNpc), locus coeruleus, and ventral tegmental area in Parkinson disease (PD); the specific aims were (a) to study regional magnetic resonance (MR) quantifiable depigmentation in association with PD severity and (b) to investigate whether imaging- and platform-dependent signal intensity variations can be normalized. Materials and Methods: This prospective case-control study was approved by the local ethics committee and the research department of Nottingham University Hospitals. Written informed consent was obtained from all participants before enrollment in the study. Sixty-nine participants (39 patients with PD and 30 control subjects) were investigated with neuromelanin-sensitive MR imaging by using two different 3-T platforms and three differing protocols. Neuromelanin-related volumes of the anterior and posterior SNpc, locus coeruleus, and ventral tegmental area were determined, and normalized neuromelanin volumes were assessed for protocol-dependent effects. Diagnostic test performance of normalized neuromelanin volume was investigated by using receiver operating characteristic analyses, and correlations with the Unified Parkinson’s Disease Rating Scale scores were tested. Results: Reduction of normalized neuromelanin volume in PD was most pronounced in the posterior SNpc (median, −83%; P < .001), followed by the anterior SNpc (−49%; P < .001) and the locus coeruleus (−37%; P < .05). Normalized neuromelanin volume loss of the posterior and whole SNpc allowed the best differentiation of patients with PD and control subjects (area under the receiver operating characteristic curve, 0.92 and 0.88, respectively). Normalized neuromelanin volume of the anterior, posterior, and whole SNpc correlated with Unified Parkinson’s Disease Rating Scale scores (r2 = 0.25, 0.22, and 0.28, respectively; all P < .05). Conclusion: PD-induced neuromelanin loss can be quantified across imaging protocols and platforms by using appropriate adjustment. Depigmentation in PD follows a distinct spatial pattern, affords high diagnostic accuracy, and is associated with disease severity.
first_indexed 2025-11-14T19:40:19Z
format Article
id nottingham-39965
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:40:19Z
publishDate 2016
publisher Radiological Society of North America
recordtype eprints
repository_type Digital Repository
spelling nottingham-399652020-05-04T18:22:12Z https://eprints.nottingham.ac.uk/39965/ In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies Schwarz, Stefan Theodor Xing, Yue Tomar, Pragya Bajaj, Nin Auer, Dorothee P. Purpose: To investigate the pattern of neuromelanin signal intensity loss within the substantia nigra pars compacta (SNpc), locus coeruleus, and ventral tegmental area in Parkinson disease (PD); the specific aims were (a) to study regional magnetic resonance (MR) quantifiable depigmentation in association with PD severity and (b) to investigate whether imaging- and platform-dependent signal intensity variations can be normalized. Materials and Methods: This prospective case-control study was approved by the local ethics committee and the research department of Nottingham University Hospitals. Written informed consent was obtained from all participants before enrollment in the study. Sixty-nine participants (39 patients with PD and 30 control subjects) were investigated with neuromelanin-sensitive MR imaging by using two different 3-T platforms and three differing protocols. Neuromelanin-related volumes of the anterior and posterior SNpc, locus coeruleus, and ventral tegmental area were determined, and normalized neuromelanin volumes were assessed for protocol-dependent effects. Diagnostic test performance of normalized neuromelanin volume was investigated by using receiver operating characteristic analyses, and correlations with the Unified Parkinson’s Disease Rating Scale scores were tested. Results: Reduction of normalized neuromelanin volume in PD was most pronounced in the posterior SNpc (median, −83%; P < .001), followed by the anterior SNpc (−49%; P < .001) and the locus coeruleus (−37%; P < .05). Normalized neuromelanin volume loss of the posterior and whole SNpc allowed the best differentiation of patients with PD and control subjects (area under the receiver operating characteristic curve, 0.92 and 0.88, respectively). Normalized neuromelanin volume of the anterior, posterior, and whole SNpc correlated with Unified Parkinson’s Disease Rating Scale scores (r2 = 0.25, 0.22, and 0.28, respectively; all P < .05). Conclusion: PD-induced neuromelanin loss can be quantified across imaging protocols and platforms by using appropriate adjustment. Depigmentation in PD follows a distinct spatial pattern, affords high diagnostic accuracy, and is associated with disease severity. Radiological Society of North America 2016-11-07 Article PeerReviewed Schwarz, Stefan Theodor, Xing, Yue, Tomar, Pragya, Bajaj, Nin and Auer, Dorothee P. (2016) In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies. Radiology . ISSN 1527-1315 http://pubs.rsna.org/doi/10.1148/radiol.2016160662 doi:10.1148/radiol.2016160662 doi:10.1148/radiol.2016160662
spellingShingle Schwarz, Stefan Theodor
Xing, Yue
Tomar, Pragya
Bajaj, Nin
Auer, Dorothee P.
In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies
title In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies
title_full In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies
title_fullStr In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies
title_full_unstemmed In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies
title_short In vivo assessment of brainstem depigmentation in Parkinson’s: potential as severity marker for multi-centre studies
title_sort in vivo assessment of brainstem depigmentation in parkinson’s: potential as severity marker for multi-centre studies
url https://eprints.nottingham.ac.uk/39965/
https://eprints.nottingham.ac.uk/39965/
https://eprints.nottingham.ac.uk/39965/